These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26972939)

  • 1. Clinicopathological Implications of Wingless/int1 (WNT) Signaling Pathway in Pancreatic Ductal Adenocarcinoma.
    Nakamoto M; Hisaoka M
    J UOEH; 2016 Mar; 38(1):1-8. PubMed ID: 26972939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets.
    Witkiewicz AK; McMillan EA; Balaji U; Baek G; Lin WC; Mansour J; Mollaee M; Wagner KU; Koduru P; Yopp A; Choti MA; Yeo CJ; McCue P; White MA; Knudsen ES
    Nat Commun; 2015 Apr; 6():6744. PubMed ID: 25855536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coupling G2/M arrest to the Wnt/β-catenin pathway restrains pancreatic adenocarcinoma.
    Sarkar S; Mandal C; Sangwan R; Mandal C
    Endocr Relat Cancer; 2014 Feb; 21(1):113-25. PubMed ID: 24402132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
    Yamaguchi T; Ikehara S; Nakanishi H; Ikehara Y
    J Pathol; 2014 Oct; 234(2):228-38. PubMed ID: 25042889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Adenomatous Polyposis Coli Loss on Tumorigenic Potential in Pancreatic Ductal Adenocarcinoma.
    Cole JM; Simmons K; Prosperi JR
    Cells; 2019 Sep; 8(9):. PubMed ID: 31540078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canonical wnt signaling is required for pancreatic carcinogenesis.
    Zhang Y; Morris JP; Yan W; Schofield HK; Gurney A; Simeone DM; Millar SE; Hoey T; Hebrok M; Pasca di Magliano M
    Cancer Res; 2013 Aug; 73(15):4909-22. PubMed ID: 23761328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium sensing receptor suppresses human pancreatic tumorigenesis through a novel NCX1/Ca(2+)/β-catenin signaling pathway.
    Tang B; Chow JY; Dong TX; Yang SM; Lu DS; Carethers JM; Dong H
    Cancer Lett; 2016 Jul; 377(1):44-54. PubMed ID: 27108064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of WNT signaling in pancreatic ductal adenocarcinoma.
    Nakamoto M; Matsuyama A; Shiba E; Shibuya R; Kasai T; Yamaguchi K; Hisaoka M
    Virchows Arch; 2014 Oct; 465(4):401-8. PubMed ID: 25146168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERO1L promotes pancreatic cancer cell progression through activating the Wnt/catenin pathway.
    Han F; Xu Q; Zhao J; Xiong P; Liu J
    J Cell Biochem; 2018 Nov; 119(11):8996-9005. PubMed ID: 30076651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKCι Is a Promising Prognosis Biomarker and Therapeutic Target for Pancreatic Cancer.
    Abdelatty A; Fang D; Wei G; Wu F; Zhang C; Xu H; Yao C; Wang Y; Xia H
    Pathobiology; 2022; 89(6):370-381. PubMed ID: 35785767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of intraductal papillary mucinous neoplasm and intraductal papillary mucinous neoplasm-derived pancreatic ductal adenocarcinoma.
    Fukuda A
    J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):519-23. PubMed ID: 25900667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers.
    White BD; Chien AJ; Dawson DW
    Gastroenterology; 2012 Feb; 142(2):219-32. PubMed ID: 22155636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma.
    Morris JP; Wang SC; Hebrok M
    Nat Rev Cancer; 2010 Oct; 10(10):683-95. PubMed ID: 20814421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular genetics of pancreatic ductal carcinoma.
    Sohn TA
    Minerva Chir; 2002 Oct; 57(5):561-74. PubMed ID: 12370658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of the ductal pancreatic adenocarcinoma: implications for future therapies?].
    Schneider G; Schmid RM
    Internist (Berl); 2005 Feb; 46(2):157-65. PubMed ID: 15655682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic progression of pancreatic cancer.
    Cowan RW; Maitra A
    Cancer J; 2014; 20(1):80-4. PubMed ID: 24445769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where and when does pancreatic carcinoma start?
    Lüttges J; Hahn S; Klöppel G
    Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma.
    Jiang X; Hao HX; Growney JD; Woolfenden S; Bottiglio C; Ng N; Lu B; Hsieh MH; Bagdasarian L; Meyer R; Smith TR; Avello M; Charlat O; Xie Y; Porter JA; Pan S; Liu J; McLaughlin ME; Cong F
    Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12649-54. PubMed ID: 23847203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
    Adsay NV; Basturk O; Cheng JD; Andea AA
    Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.